Sunstone Life Science Ventures (investor - Venture Capital)

sunstone.eu

See something wrong or missing? Let us know

Offices:Copenhagen

Sunstone Life Science Ventures, headquartered in Copenhagen and founded in 2007, is a life science venture investment capital company.

Average round investment:37.11M USD

Average number per year:1.9

Distribution: 2025 (1)2024 (1)2023 (5)2022 (2)2021 (3) See the entire list

Portfolio companies: France

Step Pharma Denmark

Neumirna Therapeutics Italy

Resalis See the entire list

Mostly invests in: Denmark

Denmark (16) Biotech (23)

See the entire list

Showing 3 of 26 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Sunstone Life Science Ventures mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Sunstone Life Science Ventures

Name		Criteria
	Lundbeckfond Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, Netherlands, Sweden Average number of deals per year: 2.0 Active last 12 months: Yes
	+ND Capital 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, Switzerland Average number of deals per year: 2.0 Active last 12 months: Yes
	Nvidia 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: France Average number of deals per year: 2.0 Active last 12 months: Yes
	V-Bio Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, France, Italy Average number of deals per year: 2.1 Active last 12 months: Yes
	Creadev 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Manufacturing Similar business models: B2B Common investees countries: France Average number of deals per year: 2.2 Active last 12 months: Yes
	HealthCap 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, Germany, Sweden Average number of deals per year: 2.2 Active last 12 months: Yes
	Bosch Ventures 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Manufacturing Similar business models: B2B Common investees countries: France, Italy, Germany, Switzerland, Finland, Sweden Average number of deals per year: 2.3 Active last 12 months: Yes
	Roche Venture Fund 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, France, Italy, Switzerland Average number of deals per year: 1.5 Active last 12 months: Yes
	Wellington Partners 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Pharma, Manufacturing Similar business models: B2B Common investees countries: Denmark, Netherlands, France, Italy, Germany, Switzerland, Finland, Sweden Average number of deals per year: 2.9 Active last 12 months: Yes
	LBO France 83%	Range for average deal size: 20M - 50M USD Similar verticals: Biotech, Health services, Manufacturing Similar business models: B2B Common investees countries: France Average number of deals per year: 3.0 Active last 12 months: Yes